Navigation Links
Misys Announces Preliminary Results for the Year Ended 31 May 2008
Date:7/24/2008

LONDON, July 24 /PRNewswire-FirstCall/ --

Key Highlights

Misys plc (LSE: MSY) delivers results ahead of expectations and is now raising targets for the next phase of the turnaround. Misys generated Group revenues(1) of GBP492m up 6%, bringing Group operating profit(2) to GBP81m, 37% ahead of last year. Misys is executing on its strategy and entering into the next phase of the turnaround plan, building a platform for growth.

To view the Multimedia News Release, please click: http://www.prnewswire.com/mnr/misys/34124/

- Banking

- Revenue(1) GBP160m, up 5%

- Total order intake(5) GBP83m, up 8%

- Successful start to implementation of Misys BankFusion with

First customer contract signed

- Treasury & Capital Markets (TCM)

- Revenue(1) GBP141m, up 13%

- Total order intake(5) GBP73m, up 16%

- Launched strategic partnerships and new revenue generating

services

- Healthcare

- Revenue(1) from continuing operations GBP191m, up 2%

- Total order intake(5) GBP103m, up 2%

- Stabilised, reorganised and positioned the business for growth

- Proposed merger with Allscripts on track

- Global Services (Note: revenue and total order intake included within

above business units)

- Revenue(1) GBP83m, up 19%

- Total order intake(5) GBP83m, up 16%

- Launched upgrade solution centre in India

- Open Source Solutions

- Division launched in July 2007 to drive innovation

- Focused on two key market opportunities, connecting healthcare

communities and carbon trading

Financial Performance

- Statutory revenue: GBP492m an increase of 5% (2007: GBP469m)

- Like for like revenue(1): GBP492m an increase of 6% (2007: GBP464m)

- Statutory operating profit: GBP52m an increase of 179% (2007: GBP19m)

- Like for like operating profit(2): GBP81m an increase of 37% (2007:

GBP59m)

- Earnings per share: basic 23.5p (2007: 3.1p); adjusted basic earnings

per share from continuing operations(3) 12.6p (2007: 7.5p)

- Full year dividends: 7.91p (2007: 7.53p)

Mike Lawrie, Chief Executive, Commented:

"Our performance over the last 12 months shows that we are ahead in executing our strategy, delivering improvements for our customers and achieving good results in demanding conditions. We have taken costs out ahead of schedule, divested non-strategic assets, realigned the business, strengthened the management team, invested in new products and services and established winning partnerships that enable us to open up new high growth markets."

"Misys has delivered ahead of schedule on our targets we outlined for the first phase of the turnaround set out in the March 2007 strategy presentation. As we move into the second phase of the turnaround and in light of the progress we have made, we think it appropriate to update the strategic goals for this new phase of the turnaround."

"While we remain vigilant to the challenges posed by the macro-economic backdrop, our geographic business mix, together with our high levels of recurring revenue, give us confidence in our ability to continue to perform. We will sharpen our focus on competing harder, winning more, and entering into new high growth markets. Achieving these goals will establish a longer term platform for growth."

Webcast and dial in facility

A live webcast of the presentation to analysts will be available on the Company's website at http://www.misys.com from 09.00 today and will be available on demand from approximately 14.00.

A listen-only dial in facility will also be available. To access this call please dial +44(0)20-8609-0582.

A results interview with Mike Lawrie, Chief Executive will be available from 07.00 on http://www.misys.com and on http://www.cantos.com.

About Misys plc

Misys plc (LSE: MSY) provides integrated, comprehensive solutions that deliver significant results to organisations in the financial services and healthcare industries. We maximise value for our customers by combining deep knowledge of their business with our commitment to their success.

In Banking and Treasury & Capital Markets, Misys is a market leader, with over 1,200 customers, including all of the world's top 50 banks. In Healthcare, Misys is a market leader, serving more than 110,000 physicians in 18,000 practice locations and 600 home care providers. Misys employs around 4,500 people who serve customers in more than 120 countries.

We aspire to be the world's best application software and services company, delivering results for the most important industries in the world.

Misys: Experience, Solutions, Results

Notes

(1) On a like for like basis, which is at constant exchange rates for continuing operations, excludes disposals and the incremental benefit of acquisitions.

(2) Excludes exceptional items, gains and losses on embedded derivatives, amortisation of acquired intangibles, translation exchange differences recycled from reserves and the impact of acquisitions and disposals and is stated at constant exchange rates.

(3) Excludes the results from discontinued operations, exceptional items, gains and losses on embedded derivatives, amortisation of acquired intangibles and the impact of translation exchange differences recycled from reserves and is based on an average number of shares in issue of 483m.

(4) Excludes exceptional items, gains and losses on embedded derivatives, amortisation of acquired intangibles and the impact of translation exchange differences recycled from reserves.

(5) Total order intake is presented on a gross basis reflecting contracts signed during the fiscal year. Prior year amounts were previously reported on a net basis, however for comparative purposes 2007 has been restated to a gross basis.

Full details of Misys Preliminary Results for the fiscal year ended 31 May 2008 can be found at http://www.misys.com

Analyst / Investor Inquiries

John Kiernan

T: +44(0)207-368-2336

M: +1-646-233-9954

Email: john.kiernan@misys.com

Media Inquiries

Carl Gibson

T: +44(0)207-368-2344

M: +44(0)782-523-6473

Email: carl.gibson@misys.com


'/>"/>
SOURCE Misys plc
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Alta Bates Medical Group (ABMG) Teams With Illumisys, LLC to Promote Quality of Care to Patients and Increase Adoption and Use of Health Information Technologies.
2. Antitrust Waiting Period Expires on Allscripts-Misys Merger Agreement
3. Misys Wins Prestigious Gold Labels From SWIFT for Entire Trade Services Solutions Portfolio
4. Misys Facilitates Masraf Al Rayans Expansion of Islamic Banking Operations
5. Commerzbank Goes Live With Misys Risk Vision 5.4, Following a Successful, On Schedule Implementation Project
6. Mybank Goes Live With Misys Equation to Support Rapid Growth and Meet Future Regulatory Requirements
7. United Commercial Bank Extends its Use of Misys Equation and Trade Innovation Systems to Support its Expansion in Taiwan
8. Cardiome Announces Preferred Share Financing
9. Mercy Health Plans Announces New Name for Their Medicare Advantage Plans: Mercy Medicare Advantage
10. American Heart Associations Announces Call for Entries for Howard L. Lewis Achievement Award
11. The Risk Management and Patient Safety Institute Announces 2008/2009 Annual Risk Management Conference, Dates
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2016)... ... May 24, 2016 , ... Mental health watchdog ... Church of Scientology and renowned professor of psychiatry Thomas Szasz, is continuing its protest ... An Industry of Death” exhibit in Atlanta, Georgia. The opening of the exhibit follows ...
(Date:5/24/2016)... , ... May 24, 2016 , ... Boyd Industries, a ... Delivery Unit® (CDU), a groundbreaking new product for pediatric dentistry , at AAPD ... in San Antonio, TX May 26-29. The Concealed Delivery Unit keeps dental hand pieces ...
(Date:5/24/2016)... ... May 24, 2016 , ... ... and clinical practice of radiosurgery, is recognizing five medical residents and students for ... stereotactic body radiotherapy (SBRT). The awards will be presented at the 2016 SRS/SBRT ...
(Date:5/24/2016)... ... May 24, 2016 , ... As reported by MassGeneral.org, on May ... transplant in the United States . The 64-year-old patient who received the transplant had ... could restore not only a natural appearance, but also urinary and sexual function for ...
(Date:5/24/2016)... ... May 24, 2016 , ... Harvard Health Publications, the consumer ... will deliver a new series of Q&A videos to clinicians and patients at ... expertise of Harvard Medical School faculty into brief videos that clinicians using vidscrip ...
Breaking Medicine News(10 mins):
(Date:5/23/2016)... May 23, 2016 Gamida Cell, ... treatment of cancer and orphan genetic diseases, announced today ... $4.4 million from the Israel Innovation Authority (formerly the ... of Economy and Industry. The mission of the Israel ... various industries, including science and technology, while stimulating economic ...
(Date:5/20/2016)... 20, 2016 The Biotech arena ... that the industry is not far from recovering. There ... featured the following four equities: Anacor Pharmaceuticals Inc. (NASDAQ: ... ATHX ), Aralez Pharmaceuticals Inc. (NASDAQ: ARLZ ... ). Sign up for your free trading alerts on ...
(Date:5/19/2016)... PARIS , May 19,2016 ... Activities at Digestive Disease Week Meeting and 91 ... Society Mauna Kea Technologies (Euronext: MKEA, ... laser endomicroscopy platform, today announced that its Cellvizio ... meeting focused on gastroenterology during the month of ...
Breaking Medicine Technology: